ALLMedicine™ Solar Urticaria Center
Research & Reviews 36 results
http://emedicine.medscape.com/article/1050485-overview
Apr 11th, 2022 - Practice Essentials Solar urticaria is a rare, IgE-mediated, photodermatosis characterized by pruritus, stinging, erythema, and wheal formation after a brief period of exposure to natural sunlight or an artificial light source emitting the appropr...
https://emedicine.medscape.com/article/1050485-treatment
Apr 11th, 2022 - Approach Considerations Long-acting, nonsedating H1-receptor blockers are the first line of treatment for solar urticaria. This is because the disease involves immunoglobulin E (IgE)-mediated mast cell degranulation with consequent histamine relea...
https://emedicine.medscape.com/article/1050485-print
Apr 11th, 2022 - Practice Essentials Solar urticaria is a rare, IgE-mediated, photodermatosis characterized by pruritus, stinging, erythema, and wheal formation after a brief period of exposure to natural sunlight or an artificial light source emitting the appropr...
https://emedicine.medscape.com/article/1050485-overview
Apr 11th, 2022 - Practice Essentials Solar urticaria is a rare, IgE-mediated, photodermatosis characterized by pruritus, stinging, erythema, and wheal formation after a brief period of exposure to natural sunlight or an artificial light source emitting the appropr...
https://clinicaltrials.gov/ct2/show/NCT02904798
Mar 3rd, 2022 - Polypodium Leucotomos (PL), a tropical fern that is grown in Central America, has been found to contain active compounds that provide antioxidative, photoprotective, chemoprotective, anti-inflammatory, and immunomodulatory properties.The antioxida...
Clinicaltrials.gov 3 results
https://clinicaltrials.gov/ct2/show/NCT02904798
Mar 3rd, 2022 - Polypodium Leucotomos (PL), a tropical fern that is grown in Central America, has been found to contain active compounds that provide antioxidative, photoprotective, chemoprotective, anti-inflammatory, and immunomodulatory properties.The antioxida...
https://clinicaltrials.gov/ct2/show/NCT01360658
Jul 30th, 2013 - Solar urticaria is a rare but debilitating disease that can severely impact the quality of life, restricting outdoor activities.Treatment, based on sun protection and anti-histaminic drugs, is efficacious in 2 patients out of 3. In refractory pati...
https://clinicaltrials.gov/ct2/show/NCT00859534
Sep 15th, 2009 - When human skin is exposed to ultraviolet radiation from the sun or via the use of solaria, it responds by increasing melanin levels within epidermal melanocytes. Ultraviolet light enhances the local production and release of alpha-melanocyte stim...
News 5 results
https://www.medscape.com/viewarticle/951252
May 17th, 2021 - Dermatologists and other clinicians should advise their patients with skin of color to practice sensible sun protection, including wearing protective clothing, staying in the shade when outdoors, and applying a tinted sunscreen with an SPF of 30 o...
https://www.mdedge.com/dermatology/article/205157/urticaria/solar-urticaria-treated-omalizumab?channel=44
William C. Schaffenburg, MD, Karen T. Guerrero, MD et. al.
Jul 23rd, 2019 - To the Editor: First documented in 1904,1 solar urticaria is an IgE-induced condition that predominantly occurs in women aged 20 to 50 years. Worldwide prevalence and incidence information is lacking, but it is known to occur in up to 0.
https://reference.medscape.com/viewarticle/898940_3
Jul 9th, 2018 - Treatment of solar urticaria can be frustrating. A combination of different modalities is often necessary, but the success of these methods is highly variable. Taking measures to avoid or minimize sun exposure is the most important step for patien...
https://www.mdedge.com/internalmedicine/article/18244/rheumatology/afamelanotide-implants-effective-erythropoietic
Bruce Jancin
GOTHENBURG, SWEDEN – A resorbable subcutaneous implant of afamelanotide significantly reduced painful phototoxic attacks in patients with erythropoietic protoporphyria in a year-long multinational clinical trial. Photo: (C) 2009 Lecha et al.
https://www.medscape.com/viewarticle/905916
Abstract and Introduction Abstract Afamelanotide, an α-melanocyte stimulating hormone analogue, has become an emerging therapeutic option for a variety of skin conditions previously refractory to other treatments. Its efficacy has been demonstrate...